Financials data is unavailable for this security.
View more
Year on year Fujian Aonong Biological Technology Group Incorporation Ltd 's revenues fell -9.97% from 21.61bn to 19.46bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 1.04bn to a larger loss of 3.65bn.
| Gross margin | -3.02% |
|---|---|
| Net profit margin | -28.45% |
| Operating margin | -25.90% |
| Return on assets | -22.49% |
|---|---|
| Return on equity | -- |
| Return on investment | -179.85% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Fujian Aonong Biological Technology Group Incorporation Ltd fell by 470.46m. However, the company earned 984.01m from its operations for a Cash Flow Margin of 5.06%. In addition the company used 322.08m on investing activities and also paid 1.13bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -2.09 |
|---|---|
| Tangible book value per share | -3.00 |
More ▼
Balance sheet in CNYView more
| Current ratio | 0.1876 |
|---|---|
| Quick ratio | 0.1219 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 1.24 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items dropped -214.18%.
| Div yield(5 year avg) | 0.40% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -79.02 |
More ▼
